Khorashad, J S
Tantravahi, S K
Yan, D
Mason, C C
Qiao, Y
Eiring, A M
Gligorich, K
Hein, T
Pomicter, A D
Reid, A G
Kelley, T W
Marth, G T
O'Hare, T
Deininger, M W
Article History
First Online: 2 August 2016
Competing interests
: MWD is on the advisory board and is a consultant for Ariad, Incyte, Novartis and Pfizer, and serves on the advisory board for CTI BioPharma Corp. His laboratory receives research funding from Bristol-Myers Squibb, Celgene, Gilead and Novartis. The remaining authors declare no conflict of interest.